NewsBenzingaKaryopharm Therapeutics Extends Forbearance Period End Date To November 1, 2026 Karyopharm Therapeutics Extends Forbearance Period End Date To November 1, 2026 Benzinga 2026.10.22 20:47 (GMT+0) Open on Benzinga Other news Stifel Maintains Buy on CACI International, Raises Price Target to $925 Rosenblatt Maintains Buy on SentinelOne, Raises Price Target to $28 Dr Reddy's Laboratories Q2 EPS $0.12 Misses $0.16 Estimate, Sales $905.000M Miss $980.650M Estimate Stifel Maintains Hold on Boyd Gaming, Lowers Price Target to $80 Wedbush Maintains Outperform on Avalo Therapeutics, Lowers Price Target to $22 Republic Bancorp Q3 EPS $1.59 Misses $1.66 Estimate, Sales $85.672M Miss $100.200M Estimate
